0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
INFLUENTIAL PUBLICATIONS   |    
Bibliography for Psychosomatic Medicine
FOCUS 2009;7:365-368.

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.

Abstract Teaser
Figures in this Article

Carney RM, Freedland KE: Depression and heart rate variability in patients with coronary heart disease.  Cleve Clin J Med 2009; 76( suppl 2): S13— S17
[PubMed]
[CrossRef]
 
Blumenthal JA: Depression and coronary artery disease: the association, mechanisms, and therapeutic implications.  Cleve Clin J Med 2008; 75( suppl 2): S48— S53
[PubMed]
[CrossRef]
 
Hackett ML, Anderson CS, House A, Xia J: Interventions for treating depression after stroke.  Cochrane Database Syst Rev 2008; 8: CD003437
 
Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES: Depression and coronary heart disease: recommendations for screening, referral, and treatment: a Science Advisory from the American Heart Association. Circulation 2008; 118: 1768— 1775
[PubMed]
[CrossRef]
 
O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR: Antidepressant use, depression, and survival in patients with heart failure.  Arch Intern Med 2008; 168: 2232— 2237
[PubMed]
[CrossRef]
 
Robinson RG, Spalletta G, Jorge RE, Bassi A, Colivicchi F, Ripa A, Caltagirone C: Decreased heart rate variability is associated with poststroke depression.  Am J Geriatr Psychiatry 2008; 16: 867— 873
[PubMed]
[CrossRef]
 
Shapiro PA: Depression in coronary artery disease: does treatment help?  Cleve Clin J Med 2008; 75( suppl 2): S5— S9
 
Taylor D: Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety.  Acta Psychiatr Scand 2008; 118: 434— 432
[PubMed]
[CrossRef]
 
Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, Zuidersma M, Eze-Nliam C, Lima BB, Smith CG, Soderlund K, Ziegelstein RC: Depression screening and patient outcomes in cardiovascular care: a systematic review.  JAMA 2008; 300: 2161— 2171
[PubMed]
[CrossRef]
 
Glassman AH: Depression and cardiovascular comorbidity.  Dialogues Clin Neurosci 2007; 9: 9— 17
[PubMed]
 
Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC, CREATE Investigators: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.  JAMA 2007; 297: 367— 379
[PubMed]
[CrossRef]
 
Narushima K, Paradiso S, Moser DJ, Jorge R, Robinson RG: Effect of antidepressant therapy on executive function after stroke. Br J Psychiatry 2007; 190: 260— 265
[PubMed]
[CrossRef]
 
Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR: Onset of major depression associated with acute coronary syndromes.  Arch Gen Psychiatry 2006; 63: 283— 288
[PubMed]
[CrossRef]
 
Schulman JK, Muskin PR, Shapiro PA: Psychiatry and cardiovascular disease.  Focus 2005; 3: 208— 224
 
van Melle JP, de Jonge P, Spijkerman TA, Tijssen JGP, Ormel J, van Veldhuisen DJ, van den Brink RHS, van den Berg MP. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis.  Psychosom Med 2004; 66: 814— 822
[PubMed]
[CrossRef]
 
References Container
Marcus MD, Kalarchian MA, Courcoulas AP: Psychiatric evaluation and follow-up of bariatric surgery patients.  Am J Psychiatry 2009; 166: 285— 291
[PubMed]
[CrossRef]
 
Alvarez-Jiménez M, González-Blanch C, Crespo-Facorro B, Hetrick S, Rodríguez-Sánchez JM, Pérez-Iglesias R, Vázquez-Barquero JL: Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders.  CNS Drugs 2008; 22: 547— 562
[PubMed]
[CrossRef]
 
Alvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD: Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.  Br J Psychiatry 2008; 193: 101— 107
[PubMed]
[CrossRef]
 
Baptista T, ElFakih Y, Uzcátegui E, Sandia I, Tálamo E, Araujo de Baptista E, Beaulieu S: Pharmacological management of antipsychotic-induced weight gain.  CNS Drugs 2008; 22: 477— 495
[PubMed]
[CrossRef]
 
Vieweg WV, Levy JR, Fredrickson SK, Chipkin SR, Beatty-Brooks M, Fernandez A, Hasnain M, Pandurangi AK: Psychotropic drug considerations in depressed patients with metabolic disturbances.  Am J Med 2008; 121: 647— 655
[PubMed]
[CrossRef]
 
Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia.  Cochrane Database Syst Rev 2007; 1: CD005148
[PubMed]
 
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes.  Diabetes Care 2004; 27: 2086— 2087
[PubMed]
[CrossRef]
 
References Container
Henningsen P, Zipfel S, Herzog W: Management of functional somatic syndromes.  Lancet 2007; 369: 946
[PubMed]
[CrossRef]
 
Kirmayer JL, Sartorius N: Cultural models and somatic syndromes.  Psychosom Med 2007; 69: 832— 840
[PubMed]
[CrossRef]
 
Kroenke K: Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007; 69: 881— 888
[PubMed]
[CrossRef]
 
Sumathipala A: What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies.  Psychosom Med 2007; 69: 889— 900
[PubMed]
[CrossRef]
 
Stonnington CM, Barry JJ, Fisher RS: Conversion disorder.  Am J Psychiatry 2006; 163: 1510— 1517
[PubMed]
[CrossRef]
 
Phillips KA: Clinical features and treatment of body dysmorphic disorder.  Focus 2005; 3: 179— 183
 
Fallon BA: Pharmacotherapy of somatoform disorders.  J Psychosom Res 2004; 56: 455— 460
[PubMed]
[CrossRef]
 
Piontek CM: Hypochondriasis—modern perspectives on an ancient malady.  Psychosomatics 2002; 43: 433— 434
[CrossRef]
 
References Container
Ferrando SJ: Psychopharmacologic treatment of patients with HIV/AIDS.  Curr Psychiatry Rep 2009; 11: 235— 242
[PubMed]
[CrossRef]
 
Sullivan EV: Special section of neuropsychology review on HIV/NeuroAIDS.  Neuropsychol Rev 2009; 19: 143
[PubMed]
[CrossRef]
 
Atkinson JH, Heaton RK, Patterson TL, Wolfson T, Deutsch R, Brown SJ, Summers J, Sciolla A, Gutierrez R, Ellis RJ, Abramson I, Hesselink JR, McCutchan JA, Grant I, HNRC Group: Two-year prospective study of major depressive disorder in HIV-infected men.  J Affect Disord 2008; 108: 225— 234
[PubMed]
[CrossRef]
 
Ferrando SJ, Freyberg Z: Treatment of depression in HIV positive individuals: a critical review.  Int Rev Psychiatry 2008; 20: 61— 71
[PubMed]
[CrossRef]
 
Klimas N, O'Brien Koneru A, Fletcher MA: Overview of HIV.  Psychosom Med 2008; 70: 523— 530
[PubMed]
[CrossRef]
 
Leserman J: Role of depression, stress, and trauma in HIV disease progression.  Psychosom Med 2008; 70: 539— 545
[PubMed]
[CrossRef]
 
Minagar A, Commins D, Alexander JS, Hoque R, Chiappelli F, Singer EJ, Nikbin B, Shapshak P: NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.  Mol Diagn Ther 2008; 12: 25— 43
[PubMed]
 
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE: Updated research nosology for HIV-associated neurocognitive disorders.  Neurology 2007; 69: 1789— 1799
[PubMed]
[CrossRef]
 
Berger-Greenstein JA, Cuevas CA, Brady SM, Trezza G, Richardson MA, Keane TM: Major depression in patients with HIV/AIDS and substance abuse.  AIDS Patient Care STDS 2007; 21: 942— 955
[PubMed]
[CrossRef]
 
Pence BW, Miller WC, Gaynes BN, Eron JJ Jr: Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.  J Acquir Immune Defic Syndr 2007; 44: 159— 166
[PubMed]
[CrossRef]
 
Basu S, Chwastiak LA, Bruce RD: Clinical management of depression and anxiety in HIV-infected adults.  AIDS 2005; 19: 2057— 2067
[PubMed]
[CrossRef]
 
Rifai MA, Rosenstein DL: Hepatitis C and psychiatry.  Focus 2005; 3: 194— 202
 
References Container
Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, Perel JM, Jones-Ivy S, Bodnar LM, Singer LT: Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166: 557— 566
[PubMed]
[CrossRef]
 
ACOG Practice Bulletin: Use of psychiatric medications during pregnancy and lactation: clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2008; 111: 1001— 1020
[PubMed]
[CrossRef]
 
Bellantuono C, Migliarese G, Gentile S: Serotonin reuptake inhibitors in pregnancy and the risk of major malformation: a systemic review.  Hum Psychopharmacol 2007; 22: 121— 128
[PubMed]
[CrossRef]
 
Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, Knight BT, Gibson BB, Viguera AC, Owens MJ, Nemeroff CB, Stowe ZN: Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.  Am J Psychiatry 2007; 164: 1214— 1220
[PubMed]
[CrossRef]
 
Yonkers KA, Wisner KL, Stowe Z, Liebenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L: Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608—620.  Reprinted in Focus 2005; 3: 266— 279
 
References Container
Spina E, Santoro V, D'Arrigo C: Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.  Clin Ther 2008; 30: 1206— 1227
[PubMed]
[CrossRef]
 
Sandson NB, Armstrong SC, Cozza KL: An overview of psychotropic drug-drug interactions.  Psychosomatics 2005; 46: 464— 494
[PubMed]
[CrossRef]
 
References Container
Chism K, Kunkel EJ: Prostate cancer: issues in psychosomatic medicine.  Curr Psychiatry Rep 2009; 11: 205— 210
[PubMed]
[CrossRef]
 
Jacobsen PB: Promoting evidence-based psychosocial care for cancer patients.  Psychooncology 2009; 18: 6— 13
[PubMed]
[CrossRef]
 
Lichtenthal W, Nilsson M, Zhang B, Trice E, Kissane D, Breitbart W, Prigerson H: Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches?  Psychooncology 2009; 18: 50— 61
[PubMed]
[CrossRef]
 
Misono S, Weiss NS, Fann JR, Redman M, Yueh B: Incidence of suicide in persons with cancer.  J Clin Oncol 2008; 26: 4731— 4738
[PubMed]
[CrossRef]
 
Phillips KA, Osborne RH, Giles GG, Dite GS, Apicella C, Hopper JL, Milne RL: Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study.  J Clin Oncol 2008; 26: 4666— 4671
[PubMed]
[CrossRef]
 
Rasic DT, Belik SL, Bolton JM, Chochinov HM, Sareen J: Cancer, mental disorders, suicidal ideation and attempts in a large community sample.  Psychooncology 2008; 17: 660— 667
[PubMed]
[CrossRef]
 
Schneider KL, Shenassa E: Correlates of suicide ideation in a population-based sample of cancer patients.  J Psychosoc Oncol 2008; 26: 49— 62
[PubMed]
[CrossRef]
 
Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker J, McHugh G, Walker A, Sharpe M: Management of depression for people with cancer (SMaRT oncology 1): a randomised trial.  Lancet 2008; 372: 40— 48
[PubMed]
[CrossRef]
 
Miovic M, Block S: Psychiatric disorders in advanced cancer.  Cancer 2007; 110: 1665— 1676
[PubMed]
[CrossRef]
 
Strong V, Waters R, Hibberd C, Rush R, Cargill A, Storey D, Walker J, Wall L, Fallon M, Sharpe M. Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom study.  Br J Cancer 2007; 96: 868— 874
[PubMed]
[CrossRef]
 
Massie MJ: Prevalence of depression in patients with cancer.  J Natl Cancer Inst Monogr 2004; 32: 57— 71
[PubMed]
 
References Container
Bostwick JM, Cohen LM: Differentiating suicide from life-ending acts and end-of-life decisions: a model based on chronic kidney disease and dialysis.  Psychosomatics 2009; 50: 1— 7
[PubMed]
[CrossRef]
 
Ganzini L, Goy ER, Dobscha SK: Prevalence of depression and anxiety in patients requesting physicians' aid in dying: cross sectional survey.  BMJ 2008; 337: a1682
[PubMed]
[CrossRef]
 
Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA, Morton SC, Hughes RG, Hilton LK, Maglione M, Rhodes SL, Rolon C, Sun VC, Shekelle PG: Evidence for improving palliative care at the end of life: a systematic review.  Ann Intern Med 2008; 148: 147— 159
[PubMed]
 
Block SD: Assessing and managing depression in the terminally ill patient. Ann Intern Med 2000; 132:209—218.  Reprinted in Focus 2005; 3: 310— 319
 
Lyness JM: End-of-life care: issues relevant to the geriatric psychiatrist. Am J Geriatr Psychiatry 2004; 12:457—472.  Reprinted in Focus 2005; 3: 341— 353
 
Muskin PR: The request to die: role for a psychodynamic perspective on physician-assisted suicide.  JAMA 1998; 279: 323— 328
[PubMed]
[CrossRef]
 
References Container
Fearing MA, Inouye SK: Delirium: The American Psychiatric Publishing Textbook of Geriatric Psychiatry. Edited by Blazer DG, Steffens DC. Washington DC, American Psychiatric Publishing, 2009.  Reprinted in Focus 2009; 7: 53— 63
 
Wei LA, Fearing MA, Sternberg EJ, Inouye SK: The confusion assessment method: a systematic review of current usage.  J Am Geriatr Soc 2008; 56: 823— 830
[PubMed]
[CrossRef]
 
Maldonado JR: Delirium in the acute care setting: characteristics, diagnosis and treatment.  Crit Care Clin 2008; 24: 657— 722
[PubMed]
[CrossRef]
 
Young J, Inouye SK: Delirium in older people.  BMJ 2007; 334: 842— 846
[PubMed]
[CrossRef]
 
Cook IA: Guideline Watch:  Practice Guideline for the Treatment of Patients With Delirium .  Arlington, VA,  American Psychiatric Association, 2004. http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm
 
Engel GL, Romano J: Delirium, a syndrome of cerebral insufficiency.  J Neuropsychiatry Clin Neurosci 2004; 16: 526— 538
[PubMed]
[CrossRef]
 
Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N: Validation of the Delirium Rating Scale-revised 98: comparison with the delirium rating scale and the cognitive test for delirium.  J Neuropsychiatry Clin Neurosci 2001; 13: 229— 242
[PubMed]
[CrossRef]
 
References Container
Dobbels F, Skeans MA, Snyder JJ, Tuomari A, Maclean J, Kasiske B. Depressive disorder in renal transplantation: an analysis of Medicare claims.  Am J Kidney Dis 2008; 51: 819— 828
[PubMed]
[CrossRef]
 
Achille MA, Ouellette A, Fournier S, Vachon M, Hébert MJ. Impact of stress, distress and feelings of indebtedness on adherence to immunosuppressants following kidney transplantation.  Clin Transplant 2006; 20: 301— 306
[PubMed]
[CrossRef]
 
Crone CC, Gabriel GM: Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.  Clin pharmacokinet 2004; 43: 361— 394
[PubMed]
[CrossRef]
 
Maldonado J: Liver Transplantation in alcoholic liver disease: selection and outcome.  J Psychosom Res 2003; 55: 115— 116
 
Bunzel B, Laederach-Hofmann K: Solid organ transplantation: are there predictors for posttransplant noncompliance?  A literature overview Transplantation 2000; 70: 711— 716
 
References Container
Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, Tu W: Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial.  JAMA 2009; 27; 301: 2099— 2110
 
Rosenblum A, Marsch LA, Joseph H, Portenoy RK: Opioids and the treatment of chronic pain: controversies, current status, and future directions.  Exp Clin Psychopharmacol 2008; 16: 405— 416
[PubMed]
[CrossRef]
 
Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS: Pharmacologic management of neuropathic pain: evidence-based recommendations.  Pain 2007; 132: 237— 251
[PubMed]
[CrossRef]
 
References Container
Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJG, Goodwin RD, Kubzansky L, Lydiard B, Massie MJ, Katon W, Laden SK, Stein MB: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30:208—225.  Reprinted in Focus 2008; 6: 467— 485
 
References Container
+

References

Carney RM, Freedland KE: Depression and heart rate variability in patients with coronary heart disease.  Cleve Clin J Med 2009; 76( suppl 2): S13— S17
[PubMed]
[CrossRef]
 
Blumenthal JA: Depression and coronary artery disease: the association, mechanisms, and therapeutic implications.  Cleve Clin J Med 2008; 75( suppl 2): S48— S53
[PubMed]
[CrossRef]
 
Hackett ML, Anderson CS, House A, Xia J: Interventions for treating depression after stroke.  Cochrane Database Syst Rev 2008; 8: CD003437
 
Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES: Depression and coronary heart disease: recommendations for screening, referral, and treatment: a Science Advisory from the American Heart Association. Circulation 2008; 118: 1768— 1775
[PubMed]
[CrossRef]
 
O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR: Antidepressant use, depression, and survival in patients with heart failure.  Arch Intern Med 2008; 168: 2232— 2237
[PubMed]
[CrossRef]
 
Robinson RG, Spalletta G, Jorge RE, Bassi A, Colivicchi F, Ripa A, Caltagirone C: Decreased heart rate variability is associated with poststroke depression.  Am J Geriatr Psychiatry 2008; 16: 867— 873
[PubMed]
[CrossRef]
 
Shapiro PA: Depression in coronary artery disease: does treatment help?  Cleve Clin J Med 2008; 75( suppl 2): S5— S9
 
Taylor D: Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety.  Acta Psychiatr Scand 2008; 118: 434— 432
[PubMed]
[CrossRef]
 
Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, Zuidersma M, Eze-Nliam C, Lima BB, Smith CG, Soderlund K, Ziegelstein RC: Depression screening and patient outcomes in cardiovascular care: a systematic review.  JAMA 2008; 300: 2161— 2171
[PubMed]
[CrossRef]
 
Glassman AH: Depression and cardiovascular comorbidity.  Dialogues Clin Neurosci 2007; 9: 9— 17
[PubMed]
 
Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin MC, CREATE Investigators: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.  JAMA 2007; 297: 367— 379
[PubMed]
[CrossRef]
 
Narushima K, Paradiso S, Moser DJ, Jorge R, Robinson RG: Effect of antidepressant therapy on executive function after stroke. Br J Psychiatry 2007; 190: 260— 265
[PubMed]
[CrossRef]
 
Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR: Onset of major depression associated with acute coronary syndromes.  Arch Gen Psychiatry 2006; 63: 283— 288
[PubMed]
[CrossRef]
 
Schulman JK, Muskin PR, Shapiro PA: Psychiatry and cardiovascular disease.  Focus 2005; 3: 208— 224
 
van Melle JP, de Jonge P, Spijkerman TA, Tijssen JGP, Ormel J, van Veldhuisen DJ, van den Brink RHS, van den Berg MP. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis.  Psychosom Med 2004; 66: 814— 822
[PubMed]
[CrossRef]
 
References Container
Marcus MD, Kalarchian MA, Courcoulas AP: Psychiatric evaluation and follow-up of bariatric surgery patients.  Am J Psychiatry 2009; 166: 285— 291
[PubMed]
[CrossRef]
 
Alvarez-Jiménez M, González-Blanch C, Crespo-Facorro B, Hetrick S, Rodríguez-Sánchez JM, Pérez-Iglesias R, Vázquez-Barquero JL: Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders.  CNS Drugs 2008; 22: 547— 562
[PubMed]
[CrossRef]
 
Alvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD: Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.  Br J Psychiatry 2008; 193: 101— 107
[PubMed]
[CrossRef]
 
Baptista T, ElFakih Y, Uzcátegui E, Sandia I, Tálamo E, Araujo de Baptista E, Beaulieu S: Pharmacological management of antipsychotic-induced weight gain.  CNS Drugs 2008; 22: 477— 495
[PubMed]
[CrossRef]
 
Vieweg WV, Levy JR, Fredrickson SK, Chipkin SR, Beatty-Brooks M, Fernandez A, Hasnain M, Pandurangi AK: Psychotropic drug considerations in depressed patients with metabolic disturbances.  Am J Med 2008; 121: 647— 655
[PubMed]
[CrossRef]
 
Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia.  Cochrane Database Syst Rev 2007; 1: CD005148
[PubMed]
 
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes.  Diabetes Care 2004; 27: 2086— 2087
[PubMed]
[CrossRef]
 
References Container
Henningsen P, Zipfel S, Herzog W: Management of functional somatic syndromes.  Lancet 2007; 369: 946
[PubMed]
[CrossRef]
 
Kirmayer JL, Sartorius N: Cultural models and somatic syndromes.  Psychosom Med 2007; 69: 832— 840
[PubMed]
[CrossRef]
 
Kroenke K: Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007; 69: 881— 888
[PubMed]
[CrossRef]
 
Sumathipala A: What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies.  Psychosom Med 2007; 69: 889— 900
[PubMed]
[CrossRef]
 
Stonnington CM, Barry JJ, Fisher RS: Conversion disorder.  Am J Psychiatry 2006; 163: 1510— 1517
[PubMed]
[CrossRef]
 
Phillips KA: Clinical features and treatment of body dysmorphic disorder.  Focus 2005; 3: 179— 183
 
Fallon BA: Pharmacotherapy of somatoform disorders.  J Psychosom Res 2004; 56: 455— 460
[PubMed]
[CrossRef]
 
Piontek CM: Hypochondriasis—modern perspectives on an ancient malady.  Psychosomatics 2002; 43: 433— 434
[CrossRef]
 
References Container
Ferrando SJ: Psychopharmacologic treatment of patients with HIV/AIDS.  Curr Psychiatry Rep 2009; 11: 235— 242
[PubMed]
[CrossRef]
 
Sullivan EV: Special section of neuropsychology review on HIV/NeuroAIDS.  Neuropsychol Rev 2009; 19: 143
[PubMed]
[CrossRef]
 
Atkinson JH, Heaton RK, Patterson TL, Wolfson T, Deutsch R, Brown SJ, Summers J, Sciolla A, Gutierrez R, Ellis RJ, Abramson I, Hesselink JR, McCutchan JA, Grant I, HNRC Group: Two-year prospective study of major depressive disorder in HIV-infected men.  J Affect Disord 2008; 108: 225— 234
[PubMed]
[CrossRef]
 
Ferrando SJ, Freyberg Z: Treatment of depression in HIV positive individuals: a critical review.  Int Rev Psychiatry 2008; 20: 61— 71
[PubMed]
[CrossRef]
 
Klimas N, O'Brien Koneru A, Fletcher MA: Overview of HIV.  Psychosom Med 2008; 70: 523— 530
[PubMed]
[CrossRef]
 
Leserman J: Role of depression, stress, and trauma in HIV disease progression.  Psychosom Med 2008; 70: 539— 545
[PubMed]
[CrossRef]
 
Minagar A, Commins D, Alexander JS, Hoque R, Chiappelli F, Singer EJ, Nikbin B, Shapshak P: NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.  Mol Diagn Ther 2008; 12: 25— 43
[PubMed]
 
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE: Updated research nosology for HIV-associated neurocognitive disorders.  Neurology 2007; 69: 1789— 1799
[PubMed]
[CrossRef]
 
Berger-Greenstein JA, Cuevas CA, Brady SM, Trezza G, Richardson MA, Keane TM: Major depression in patients with HIV/AIDS and substance abuse.  AIDS Patient Care STDS 2007; 21: 942— 955
[PubMed]
[CrossRef]
 
Pence BW, Miller WC, Gaynes BN, Eron JJ Jr: Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.  J Acquir Immune Defic Syndr 2007; 44: 159— 166
[PubMed]
[CrossRef]
 
Basu S, Chwastiak LA, Bruce RD: Clinical management of depression and anxiety in HIV-infected adults.  AIDS 2005; 19: 2057— 2067
[PubMed]
[CrossRef]
 
Rifai MA, Rosenstein DL: Hepatitis C and psychiatry.  Focus 2005; 3: 194— 202
 
References Container
Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, Perel JM, Jones-Ivy S, Bodnar LM, Singer LT: Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166: 557— 566
[PubMed]
[CrossRef]
 
ACOG Practice Bulletin: Use of psychiatric medications during pregnancy and lactation: clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2008; 111: 1001— 1020
[PubMed]
[CrossRef]
 
Bellantuono C, Migliarese G, Gentile S: Serotonin reuptake inhibitors in pregnancy and the risk of major malformation: a systemic review.  Hum Psychopharmacol 2007; 22: 121— 128
[PubMed]
[CrossRef]
 
Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, Knight BT, Gibson BB, Viguera AC, Owens MJ, Nemeroff CB, Stowe ZN: Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.  Am J Psychiatry 2007; 164: 1214— 1220
[PubMed]
[CrossRef]
 
Yonkers KA, Wisner KL, Stowe Z, Liebenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L: Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608—620.  Reprinted in Focus 2005; 3: 266— 279
 
References Container
Spina E, Santoro V, D'Arrigo C: Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.  Clin Ther 2008; 30: 1206— 1227
[PubMed]
[CrossRef]
 
Sandson NB, Armstrong SC, Cozza KL: An overview of psychotropic drug-drug interactions.  Psychosomatics 2005; 46: 464— 494
[PubMed]
[CrossRef]
 
References Container
Chism K, Kunkel EJ: Prostate cancer: issues in psychosomatic medicine.  Curr Psychiatry Rep 2009; 11: 205— 210
[PubMed]
[CrossRef]
 
Jacobsen PB: Promoting evidence-based psychosocial care for cancer patients.  Psychooncology 2009; 18: 6— 13
[PubMed]
[CrossRef]
 
Lichtenthal W, Nilsson M, Zhang B, Trice E, Kissane D, Breitbart W, Prigerson H: Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches?  Psychooncology 2009; 18: 50— 61
[PubMed]
[CrossRef]
 
Misono S, Weiss NS, Fann JR, Redman M, Yueh B: Incidence of suicide in persons with cancer.  J Clin Oncol 2008; 26: 4731— 4738
[PubMed]
[CrossRef]
 
Phillips KA, Osborne RH, Giles GG, Dite GS, Apicella C, Hopper JL, Milne RL: Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study.  J Clin Oncol 2008; 26: 4666— 4671
[PubMed]
[CrossRef]
 
Rasic DT, Belik SL, Bolton JM, Chochinov HM, Sareen J: Cancer, mental disorders, suicidal ideation and attempts in a large community sample.  Psychooncology 2008; 17: 660— 667
[PubMed]
[CrossRef]
 
Schneider KL, Shenassa E: Correlates of suicide ideation in a population-based sample of cancer patients.  J Psychosoc Oncol 2008; 26: 49— 62
[PubMed]
[CrossRef]
 
Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker J, McHugh G, Walker A, Sharpe M: Management of depression for people with cancer (SMaRT oncology 1): a randomised trial.  Lancet 2008; 372: 40— 48
[PubMed]
[CrossRef]
 
Miovic M, Block S: Psychiatric disorders in advanced cancer.  Cancer 2007; 110: 1665— 1676
[PubMed]
[CrossRef]
 
Strong V, Waters R, Hibberd C, Rush R, Cargill A, Storey D, Walker J, Wall L, Fallon M, Sharpe M. Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom study.  Br J Cancer 2007; 96: 868— 874
[PubMed]
[CrossRef]
 
Massie MJ: Prevalence of depression in patients with cancer.  J Natl Cancer Inst Monogr 2004; 32: 57— 71
[PubMed]
 
References Container
Bostwick JM, Cohen LM: Differentiating suicide from life-ending acts and end-of-life decisions: a model based on chronic kidney disease and dialysis.  Psychosomatics 2009; 50: 1— 7
[PubMed]
[CrossRef]
 
Ganzini L, Goy ER, Dobscha SK: Prevalence of depression and anxiety in patients requesting physicians' aid in dying: cross sectional survey.  BMJ 2008; 337: a1682
[PubMed]
[CrossRef]
 
Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA, Morton SC, Hughes RG, Hilton LK, Maglione M, Rhodes SL, Rolon C, Sun VC, Shekelle PG: Evidence for improving palliative care at the end of life: a systematic review.  Ann Intern Med 2008; 148: 147— 159
[PubMed]
 
Block SD: Assessing and managing depression in the terminally ill patient. Ann Intern Med 2000; 132:209—218.  Reprinted in Focus 2005; 3: 310— 319
 
Lyness JM: End-of-life care: issues relevant to the geriatric psychiatrist. Am J Geriatr Psychiatry 2004; 12:457—472.  Reprinted in Focus 2005; 3: 341— 353
 
Muskin PR: The request to die: role for a psychodynamic perspective on physician-assisted suicide.  JAMA 1998; 279: 323— 328
[PubMed]
[CrossRef]
 
References Container
Fearing MA, Inouye SK: Delirium: The American Psychiatric Publishing Textbook of Geriatric Psychiatry. Edited by Blazer DG, Steffens DC. Washington DC, American Psychiatric Publishing, 2009.  Reprinted in Focus 2009; 7: 53— 63
 
Wei LA, Fearing MA, Sternberg EJ, Inouye SK: The confusion assessment method: a systematic review of current usage.  J Am Geriatr Soc 2008; 56: 823— 830
[PubMed]
[CrossRef]
 
Maldonado JR: Delirium in the acute care setting: characteristics, diagnosis and treatment.  Crit Care Clin 2008; 24: 657— 722
[PubMed]
[CrossRef]
 
Young J, Inouye SK: Delirium in older people.  BMJ 2007; 334: 842— 846
[PubMed]
[CrossRef]
 
Cook IA: Guideline Watch:  Practice Guideline for the Treatment of Patients With Delirium .  Arlington, VA,  American Psychiatric Association, 2004. http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm
 
Engel GL, Romano J: Delirium, a syndrome of cerebral insufficiency.  J Neuropsychiatry Clin Neurosci 2004; 16: 526— 538
[PubMed]
[CrossRef]
 
Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N: Validation of the Delirium Rating Scale-revised 98: comparison with the delirium rating scale and the cognitive test for delirium.  J Neuropsychiatry Clin Neurosci 2001; 13: 229— 242
[PubMed]
[CrossRef]
 
References Container
Dobbels F, Skeans MA, Snyder JJ, Tuomari A, Maclean J, Kasiske B. Depressive disorder in renal transplantation: an analysis of Medicare claims.  Am J Kidney Dis 2008; 51: 819— 828
[PubMed]
[CrossRef]
 
Achille MA, Ouellette A, Fournier S, Vachon M, Hébert MJ. Impact of stress, distress and feelings of indebtedness on adherence to immunosuppressants following kidney transplantation.  Clin Transplant 2006; 20: 301— 306
[PubMed]
[CrossRef]
 
Crone CC, Gabriel GM: Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.  Clin pharmacokinet 2004; 43: 361— 394
[PubMed]
[CrossRef]
 
Maldonado J: Liver Transplantation in alcoholic liver disease: selection and outcome.  J Psychosom Res 2003; 55: 115— 116
 
Bunzel B, Laederach-Hofmann K: Solid organ transplantation: are there predictors for posttransplant noncompliance?  A literature overview Transplantation 2000; 70: 711— 716
 
References Container
Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, Tu W: Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial.  JAMA 2009; 27; 301: 2099— 2110
 
Rosenblum A, Marsch LA, Joseph H, Portenoy RK: Opioids and the treatment of chronic pain: controversies, current status, and future directions.  Exp Clin Psychopharmacol 2008; 16: 405— 416
[PubMed]
[CrossRef]
 
Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS: Pharmacologic management of neuropathic pain: evidence-based recommendations.  Pain 2007; 132: 237— 251
[PubMed]
[CrossRef]
 
References Container
Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJG, Goodwin RD, Kubzansky L, Lydiard B, Massie MJ, Katon W, Laden SK, Stein MB: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30:208—225.  Reprinted in Focus 2008; 6: 467— 485
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Psychiatric News
Read more at Psychiatric News >>
PubMed Articles